TUCSON, Ariz.--(BUSINESS WIRE)--ImaRx Therapeutics, Inc. (NASDAQ:IMRX) today announced it has named Richard L. Love as Chairman of the Board of Directors. He succeeds Richard E. Otto, who will remain on the company’s board. Mr. Love has served on the ImaRx board since March 2006. Previously, he served as Chief Operating Officer for Translational Genomics Research Institute and from June 1993 to January 2002 served as Chief Executive Officer and a director of ILEX Oncology, Inc., a biotechnology company evaluating cancer therapeutics. Mr. Love holds bachelors and masters of science degrees in Chemical Engineering from the Virginia Polytechnic Institute.
